Overview of Dr. Crane
Dr. Christopher Crane is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of Virginia School of Medicine and has been in practice 24 years. Dr. Crane accepts several types of health insurance, listed below. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 26 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Radiation Oncology. He also speaks multiple languages, including Spanish. He has more than 100 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
- University of Virginia Medical CenterResidency, Radiation Oncology, 1994 - 1998
- Carilion Clinic-Virginia Tech Carilion School of MedicineInternship, Transitional Year, 1993 - 1994
- University of Virginia School of MedicineClass of 1993
- University of MiamiBS, 1985 - 1989
Certifications & Licensure
- FL State Medical License 2023 - Present
- NJ State Medical License 2021 - 2025
- NY State Medical License 2015 - 2025
- NC State Medical License 2021 - 2022
- TX State Medical License 1999 - 2017
- AL State Medical License 1998 - 2002
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Best Doctors Best Doctors in America, 2003-2019
- America's Top Doctors Castle Connolly, 2013-2014
- Top Doctors: Texas Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer Start of enrollment: 2002 Sep 01
- Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Start of enrollment: 2004 Apr 01
- Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer Start of enrollment: 2005 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- External Beam Radiation Therapy for Liver Metastases.Paul B Romesser, Brian P Neal, Christopher H Crane
Hematology/oncology Clinics of North America. 2025-02-01 - Clinical Outcomes, Patterns of Failure, and Salvage Therapies of a Large Modern Cohort of Patients With Anal Squamous Cell Carcinoma Treated With Definitive-Intent Int...Diana A Roth O'Brien, Vasilis C Hristidis, Zakaria Chakrani, Patrick McCann, Antonio Damato
International Journal of Radiation Oncology, Biology, Physics. 2024-11-12 - Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy.Sean J Judge, Parisa Malekzadeh, Marina J Corines, Marc J Gollub, Natally Horvat
Journal of the National Cancer Institute. 2024-11-01
Journal Articles
- A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal AdenocarcinomaShun Yu, Deyali Chatterjee, Rong Ye, Prajnan Das, Naveen Garg, Robert A Wolff, Huamin Wang, Eugene J Koay, Gauri R Varadhachary, Christopher H Crane, Milind Javle, Jef..., Clinical Cancer Research
- Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?Chadha, Awalpreet S., Crane CH, et al., International Journal of Radiation Oncology Biology Physics, 1/1/2017
- Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Koay EJ, Odisio BC, Javle M, Vauthey J-N, Crane CH., HepatoBiliary Surgery and Nutrition., 1/1/2017
- Join now to see all
Books/Book Chapters
Lectures
- Palliation Techniques for Hepato-Pancreato-Biliary TumorsASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Great Debates and Updates in Gastrointestinal MalignanciesImedex, New York, New York - 3/30/2012
- Meet the Professor Session: Esophageal CancerOrlando, FL - 1/1/2007
- Join now to see all
Press Mentions
- Role of Neoadjuvant Therapy for Resectable and Borderline-Resectable Pancreatic CancerJune 12th, 2019
- Radiation Dose Escalation to the Tumor-Arterial Interface of Locally Advanced and Borderline Resectable Pancreatic CancerJuly 10th, 2016
- Intention to Leave Position Higher Among Academic RadiologistsDecember 20th, 2023
Professional Memberships
- Member
Other Languages
- Spanish
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PowerSelect HMO
BCBS Illinois PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: